These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 27462605)
21. Essure Removal for the Treatment of Device-Attributed Symptoms: An Expanded Case Series and Follow-up Survey. Clark NV; Rademaker D; Mushinski AA; Ajao MO; Cohen SL; Einarsson JI J Minim Invasive Gynecol; 2017; 24(6):971-976. PubMed ID: 28599885 [TBL] [Abstract][Full Text] [Related]
22. Surgical excision of Essure® devices with ESHRE Class IIb uterine malformation: sequential hysteroscopic-laparoscopic approach to the septate uterus. Sills ES; Palermo GD Facts Views Vis Obgyn; 2016 Mar; 8(1):49-52. PubMed ID: 27822350 [TBL] [Abstract][Full Text] [Related]
23. Long-term quality of life after surgical Essure removal for device-attributed symptoms. Bideau M; Rathat G; Francini S; Ranisavljevic N; Crochet P; Compan C; Duflos C; Duraes M Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():138-143. PubMed ID: 36493582 [TBL] [Abstract][Full Text] [Related]
24. [Tubal obstruction with an implant inserted by hysteroscopy: a report of 50 cases]. Saad-Ganem A; Alanis-Fuentes J; López-Ortiz CG; Muradas-Gil L; Quintero-Bernal P; Palma-Dorantes J; Charua Levy E Ginecol Obstet Mex; 2014 Jul; 82(7):448-53. PubMed ID: 25102670 [TBL] [Abstract][Full Text] [Related]
25. Laparoscopic salpingectomy and removal of Essure hysteroscopic sterilisation device: a case series. Johal T; Kuruba N; Sule M; Mukhopadhyay S; Raje G Eur J Contracept Reprod Health Care; 2018 Jun; 23(3):227-230. PubMed ID: 29842838 [TBL] [Abstract][Full Text] [Related]
26. Placement of the Essure permanent birth control device with fluoroscopic guidance: a novel method for tubal sterilization. McSwain H; Shaw C; Hall LD J Vasc Interv Radiol; 2005 Jul; 16(7):1007-12. PubMed ID: 16002509 [TBL] [Abstract][Full Text] [Related]
27. Risk of Essure microinsert abdominal migration: case report and review of literature. Ricci G; Restaino S; Di Lorenzo G; Fanfani F; Scrimin F; Mangino FP Ther Clin Risk Manag; 2014; 10():963-8. PubMed ID: 25484591 [TBL] [Abstract][Full Text] [Related]
29. Essure Surgical Removal and Subsequent Resolution of Chronic Pelvic Pain: A Case Report and Review of the Literature. Lora Alcantara I; Rezai S; Kirby C; Chadee A; Henderson CE; Elmadjian M Case Rep Obstet Gynecol; 2016; 2016():6961202. PubMed ID: 26904330 [TBL] [Abstract][Full Text] [Related]
30. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Matorras R; Rabanal A; Prieto B; Diez S; Brouard I; Mendoza R; Exposito A Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):54-9. PubMed ID: 23561020 [TBL] [Abstract][Full Text] [Related]
31. Office ultrasound should be the first-line investigation for confirmation of correct ESSURE placement. Weston G; Bowditch J Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):312-5. PubMed ID: 16029299 [TBL] [Abstract][Full Text] [Related]
32. A kink is not always a perforation: assessing Essure hysteroscopic sterilization placement. Borley J; Shabajee N; Tan TL Fertil Steril; 2011 Jun; 95(7):2429.e15-7. PubMed ID: 21367412 [TBL] [Abstract][Full Text] [Related]
34. One-step transvaginal three-dimensional hysterosalpingo-foam sonography (3D-HyFoSy) confirmation test for Essure® follow-up: a multicenter study. Zizolfi B; Lazzeri L; Franchini M; Di Spiezio Sardo A; Nappi C; Piccione E; Exacoustos C Ultrasound Obstet Gynecol; 2018 Jan; 51(1):134-141. PubMed ID: 28067009 [TBL] [Abstract][Full Text] [Related]
35. Incorrect position of Essure microinserts 3 months after successful bilateral placement. Gerritse MB; Veersema S; Timmermans A; Brölmann HA Fertil Steril; 2009 Mar; 91(3):930.e1-5. PubMed ID: 18945426 [TBL] [Abstract][Full Text] [Related]
36. Unilateral placement of the Adiana device after failed bilateral placement of the Essure device for hysteroscopic sterilization. Gimpelson RJ; Wagner CA J Minim Invasive Gynecol; 2010; 17(5):660-1. PubMed ID: 20728829 [TBL] [Abstract][Full Text] [Related]
37. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study. Kerin JF; Carignan CS; Cher D Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):364-70. PubMed ID: 11787907 [TBL] [Abstract][Full Text] [Related]
38. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Mijatovic V; Veersema S; Emanuel MH; Schats R; Hompes PG Fertil Steril; 2010 Mar; 93(4):1338-42. PubMed ID: 19147140 [TBL] [Abstract][Full Text] [Related]
39. Pregnancy after Essure placement: report of two cases. Moses AW; Burgis JT; Bacon JL; Risinger J Fertil Steril; 2008 Mar; 89(3):724.e9-11. PubMed ID: 17543963 [TBL] [Abstract][Full Text] [Related]
40. Sonography, CT, and MRI appearance of the Essure microinsert permanent birth control device. Wittmer MH; Brown DL; Hartman RP; Famuyide AO; Kawashima A; King BF AJR Am J Roentgenol; 2006 Oct; 187(4):959-64. PubMed ID: 16985143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]